Encouragingly, this study offers the advantages of the translational approach in mice and humans, and further effort is worthy and needed to study the FGF19/FGFR4 axis linked to tumor-initiation in human HCC. This evidence concerns the gene FGFR4 and hepatocellular carcinoma.